source
- AI-driven biotech Fathom Therapeutics secures $47 million Series A funding and rebrands from AtommapFathom Therapeutics, the company formerly known as Atommap, announced that it has closed a $47 million Series A financing round. The capital raise will support the firm’s effort to combine artifici…
- FDA greenlights Motif Neurotech's feasibility trial of brain-implant hat for treatment-resistant depressionThe U.S. Food and Drug Administration has approved Motif Neurotech's request to begin an initial feasibility trial of its brain‑implant device aimed at patients with treatment‑resistant depression.…